Records containing: Overactive Bladder Syndrome
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-04-21Urodynamics and Clinical Factors That Are Associated With Bladder Over-sensitivity
-
CLINICAL_TRIALS study record update · 2020-02-21'The Experience Sampling Method (ESM): a Real-time Patient-Reported Outcome Measure for Symptom Assessment in Patients With Overactive Bladder Syndrome.'
-
CLINICAL_TRIALS study record update · 2019-10-25Clinical Evaluation of Herbal Patch for Overactive Bladder Patients
-
CLINICAL_TRIALS study record update · 2019-08-02A Randomized Trial of Maintenance Therapy With Posterior Tibial Nerve Stimulation for Overactive Bladder
-
CLINICAL_TRIALS study record update · 2019-04-17Transcutaneous Tibial Nerve Electrical Stimulation Combined With Transvaginal Electrical Stimulation in Overactive Bladder Syndrome Treatment: Clinical Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-03-07Far Eastern Memorial Hospital
-
CLINICAL_TRIALS study record update · 2019-02-15Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome: Randomized Blind Clinical Trial
-
CLINICAL_TRIALS study record update · 2019-01-25Assistant Professor, Physioterapist, PhD
-
CLINICAL_TRIALS study record update · 2018-11-23Central Obesity With Relation in OAB: Is it a Matter of Size or Fat Activity?. Prospective Controlled Trial
-
CLINICAL_TRIALS study record update · 2018-11-07Effectiveness of a Structured Intervention to Optimize Both the Use of Mirabegron, a β3 Receptor Agonist, and Facilitate Its Discontinuation: a Quasi-experimental Study
-
CLINICAL_TRIALS study record update · 2018-10-09Trigonal-sparing Versus Trigonal-involved Intravesical Botulinumtoxin A Injection in Refractory Idiopathic Detrusor Overactivity.
-
CLINICAL_TRIALS study record update · 2018-08-24Comparative Study of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After Transurethral Resection of the Prostate - A Randomized Prospective Study
-
CLINICAL_TRIALS study record update · 2018-08-23Description of Basic Visceral Sensations Coming From the Bladder
-
CLINICAL_TRIALS study record update · 2018-05-17Randomized,Single-Blind Controlled Trial
-
CLINICAL_TRIALS study record update · 2018-01-10Efficacy of Isometric Contraction Exercises of Lower Limbs Muscles, in Modulating Neurological Control of Bladder Function in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2017-11-06Effects of Bladder Training and Pelvic Floor Muscle Training on the Symptomatology of Overactive Bladder Syndrome - a Randomized Controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2017-05-31Overactive Bladder in Elderly Patients- An Early Warning of Coronary Artery Disease
-
CLINICAL_TRIALS study record update · 2017-05-24Validation of a Real-time Urodynamic Measure of Urinary Urgency as a Measure of the Success of Drug Treatment
-
CLINICAL_TRIALS study record update · 2017-02-23Therapeutic Efficacy and Safety of Mirabegron , a β3-Adrenoceptor Agonist, Treatment on Patients With Overactive Bladder Syndrome in Taiwan - Predictive Factors for the First Line Use and the Dose Effectiveness Relationship
-
CLINICAL_TRIALS study record update · 2017-02-09Therapeutic Efficacy and Safety of Mirabegron , a β3-Adrenoceptor Agonist, Treatment on Patients With Overactive Bladder Syndrome in Taiwan - Comparison of Therapeutic Efficacy and Safety Between 25mg and 50mg
-
CLINICAL_TRIALS study record update · 2016-09-07ClinicalTrials.gov study NCT01819168
-
CLINICAL_TRIALS study record update · 2015-07-07Comparisons of Urodynamic Effects, Urinary Nerve Growth Factor Levels and Outcomes in Female Overactive Bladder Patients After 3-month Versus 6-month Solifenacin Treatment: a Randomized Prospective Study
-
CLINICAL_TRIALS study record update · 2014-12-16ClinicalTrials.gov study NCT01559623
-
CLINICAL_TRIALS study record update · 2013-12-31Evaluation of Health-Related Quality of Life in Patients With Overactive Bladder Syndrome (OAB) Treated With Propiverine, and Its Efficacy and Tolerance in Daily Practice in Belgian General Practitioners and Urologists
-
CLINICAL_TRIALS study record update · 2012-11-15Post-treatment Normallized Urodynamic Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug and Its Correlations With Voiding Diary, King's Health Questionnaire, and Overactive Bladder Sympto